Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 3075.8"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 49859.9"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enriched"	"Detected in some"	39	"Hep G2: 315.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000		"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.1	315.9	0.0	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	0.0	2.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	683.8	0.0	0.0	0.0	0.1	12066.1	0.0	0.0	36.6	0.0	0.8	61.3	4.3	2.0	0.0	0.0	1612.0	237.4	2.3	0.2	0.1	0.0	49859.9	8.2	0.0	1.7	1417.3	1529.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	261.7	0.0	0.0	442.7	0.0	0.0	0.4	0.2	0.2	0.1	17.7	22.3	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	145	"intestine: 224.8;liver: 442.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 2874.2"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 155.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	89000000000	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	0.3	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.1	0.1	68.9	0.0	0.0	24.9	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.1	442.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	224.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.9	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	14.6	293.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.0	2874.2	0.1	0.0	0.0	51.5	53.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 702.7"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 27093.4"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"myeloid DC: 8.9"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 100.3;HSkMC: 62.1;K-562: 26.1;SK-MEL-30: 46.2"	"Low region specificity"	"Detected in many"							HPA051518	Supported				"Secreted to blood"	NA	NA	20300000000	26000000000			"HPA051518: AB_2681519"	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	1.5	58.9	6.6	1.6	30.0	2.4	3.6	0.6	4.4	1.5	1.8	4.9	0.3	0.9	0.6	2.5	0.4	0.8	1.8	0.4	4.1	7.8	0.6	702.7	12.6	6.1	20.2	1.0	4.1	1.1	0.4	2.6	2.3	6.6	0.6	1.1	1.3	2.0	0.4	1.2	1.4	1.0	0.5	11.7	9.6	1.3	1.0	5.2	1.0	0.7	0.5	1.9	1.2	0.3	0.2	8.9	0.0	0.6	0.2	0.0	0.6	0.4	4.7	2.1	0.9	6.9	7.2	20.3	0.2	0.3	0.8	1.3	9.9	8.9	1.4	1.7	0.1	0.6	0.3	2.8	0.3	0.4	0.0	11.4	6.4	0.6	100.3	6.1	4.7	3.3	62.1	0.5	0.8	0.3	1.7	0.2	0.3	26.1	0.1	0.3	0.6	0.2	0.3	20.4	1.8	1.0	1.0	2.9	0.1	1.3	0.3	0.9	0.6	3.3	0.0	46.2	7.2	0.4	17.4	0.7	0.0	0.3	0.0	0.2	0.8	0.8	1.5	0.1	1.3	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.9	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.6	6.6	30.0	0.6	3.1	4.1	7.8	20.2	1.0	6.6	5.2	107.2	247.1	115.1	4.2	15.0	1.6	0.7	451.0	44.2	99.0	1.8	0.0	32.3	41.4	3.4	0.9	5.6	0.5	186.9	3.5	299.0	64.1	1.9	139.7	27093.4	5056.0	0.0	2.4	451.8	716.3	1.3	250.8	243.1	28.7	215.6	2.2	120.9	3.3	0.0	244.0	10.9	8.3	19.4	5.9	1.4	3.0	15.6	59.8	137.1	2.1	4.9
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44945982-44949565	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease mutation, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	78	"liver: 506.5"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 936.4"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	21	"NK-cell: 6.5"	"Lineage enriched"	"Detected in single"	21	"NK-cells: 6.5"	"Group enriched"	"Detected in some"	4	"Hep G2: 84.9;THP-1: 156.9"					"Not detected"	"Not detected"			HPA055877	Supported				"Secreted to blood"	NA	NA	43000000000	110000000000			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	0.2	0.4	2.8	0.3	3.7	0.2	0.5	0.4	1.6	0.4	2.1	3.7	0.0	2.8	0.2	0.5	0.3	0.4	0.4	0.2	2.3	2.2	1.2	506.5	2.2	0.8	4.7	0.5	0.2	0.2	0.3	0.2	0.3	2.2	0.2	0.4	0.0	0.3	0.3	0.3	0.4	6.3	0.2	4.7	0.3	0.3	0.2	2.1	0.0	0.2	0.0	0.7	0.3	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.7	0.2	84.9	0.0	1.8	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	14.1	0.0	0.4	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.0	0.0	156.9	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.8	3.7	0.4	1.6	2.3	2.2	4.7	0.5	2.2	2.1	0.0	2.9	1.5	0.0	0.6	0.0	0.1	12.7	0.0	0.0	3.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.4	936.4	35.6	0.0	0.0	18.4	13.7	0.0	0.0	11.1	6.8	3.6	0.0	0.0	0.0	0.0	0.7	11.2	0.0	0.0	0.0	0.1	0.0	0.4	0.2	1.3	0.0	0.0
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 714.1"	"Cell type enriched"	"Detected in some"	60	"Hepatocytes: 64257.6"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 28.5;Hep G2: 77.0"					"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	97000000000	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	91.3	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	28.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	77.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.3	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	100.1	0.0	0.0	0.0	0.0	858.6	0.0	0.0	0.0	0.0	0.0	3.3	0.0	3.8	0.0	0.0	1074.6	0.4	0.3	0.0	0.0	0.0	64257.6	1.0	0.0	0.0	825.6	1072.7	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.2	0.0	0.0
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905754-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Hyperlipidemia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 226.8;liver: 508.1"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 7873.9;Hofbauer cells: 6293.2;Muller glia cells: 7584.1;Peritubular cells: 4660.8;Proximal tubular cells: 5645.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 167.1;CACO-2: 39.6;Hep G2: 77.6;HSkMC: 122.5;SK-MEL-30: 155.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	51800000000	63000000000	Vesicles		"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	76.8	226.8	78.4	14.6	106.8	9.7	12.8	26.6	109.8	13.6	15.1	40.3	0.8	7.7	9.4	10.9	2.6	4.3	17.1	6.9	41.4	57.9	121.8	508.1	21.5	46.0	104.0	34.5	23.5	5.2	2.7	4.9	17.2	54.1	6.6	5.2	11.2	8.5	3.4	5.7	33.0	10.2	3.6	35.1	89.2	13.4	12.6	33.9	4.9	6.0	1.3	8.6	11.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.2	167.1	6.8	6.0	0.1	0.3	0.7	0.1	39.6	0.2	0.1	0.8	0.0	0.8	0.5	1.1	0.1	0.0	0.1	0.3	0.2	0.1	77.6	17.2	0.5	0.2	122.5	0.2	1.3	0.1	1.3	0.0	0.0	10.2	0.2	0.1	0.2	0.1	0.2	20.9	0.2	0.1	0.2	0.7	0.1	0.2	0.0	0.4	0.2	0.3	0.1	155.3	12.1	14.3	4.4	0.2	1.1	0.2	0.1	0.1	0.5	0.6	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.4	106.8	26.6	53.4	41.4	57.9	104.0	34.5	54.1	33.9	0.0	10.9	128.8	14.4	830.7	52.9	1.6	384.7	0.0	5.7	216.3	39.3	36.4	578.6	1.8	57.6	21.1	0.3	163.5	0.6	28.5	329.7	3.9	179.1	7873.9	6293.2	36.5	0.0	191.5	425.6	179.9	2434.6	240.8	2353.4	122.6	0.3	7584.1	0.8	0.0	4660.8	5645.5	238.0	219.9	382.4	13.0	8.5	1472.8	62.1	122.2	1.2	4.2
BMP1	PCOLC	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22164736-22212326	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"lung: 72.2;placenta: 106.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	NA	NA		2100000			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	6.9	11.7	2.7	3.6	4.6	1.1	5.9	7.8	4.2	8.1	5.8	3.1	3.7	4.4	9.4	5.2	4.8	7.7	5.4	3.4	2.6	1.3	4.9	9.2	72.2	3.2	3.4	1.5	5.2	3.7	2.8	2.2	106.2	3.5	6.5	4.7	4.6	2.4	4.6	2.4	6.8	5.7	11.0	3.6	3.2	2.9	2.2	3.6	1.0	7.1	2.4	2.9	9.9	9.5	0.0	0.9	0.1	1.4	0.8	2.2	0.4	4.6	4.8	1.3	6.2	15.2	11.3	6.8	20.2	16.8	10.3	9.6	2.5	3.0	1.1	12.7	18.5	6.4	10.1	1.5	5.3	2.0	1.0	2.1	1.7	7.3	2.8	12.4	0.7	3.4	12.8	8.5	8.0	2.6	18.3	10.0	0.6	2.1	2.0	5.6	1.7	0.4	1.0	0.8	6.9	2.6	1.1	3.3	4.9	8.9	0.7	0.8	3.3	14.6	0.8	3.3	5.6	0.9	2.0	12.6	2.7	5.9	6.5	5.9	1.0	0.6	0.2	5.3	2.7	7.4	0.0	1.4	0.0	2.2	0.7	1.4	0.0	0.4	1.0	0.0	0.0	0.3	1.7	0.1	0.8	0.5	0.9	0.0	0.4	2.7	4.6	7.8	4.2	2.6	1.3	3.4	1.5	3.5	3.6	6.0	61.3	0.5	5.3	5.6	1.5	3.0	2.5	1.4	2.3	5.2	0.0	2.4	0.0	21.2	0.5	10.5	18.6	0.0	7.1	8.6	24.4	2.5	15.0	15.8	4.1	1.6	2.9	14.1	4.0	0.5	9.5	3.5	10.1	0.0	5.5	3.2	11.4	11.0	10.3	3.1	1.0	25.8	18.4	0.9	3.6	4.5	20.4	1.9	9.7	6.4
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719180-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	593	"liver: 324.8"	"Cell type enriched"	"Detected in some"	37	"Hepatocytes: 904.6"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 78.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	43000000000			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	324.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	78.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.6	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	904.6	0.0	0.0	0.0	24.5	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590766	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	740	"liver: 2009.3"	"Cell type enriched"	"Detected in many"	40	"Hepatocytes: 16694.6"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 96.9"	"Not detected"	"Not detected"							"CAB016776, HPA051370, HPA064755"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	170000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.7	2009.3	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	96.9	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.4	83.9	0.0	0.0	0.0	0.4	420.4	17.4	5.7	0.0	0.0	0.0	1.7	5.5	23.9	0.0	0.0	256.9	1.5	0.0	0.0	0.0	0.0	16694.6	0.1	0.0	0.0	255.3	257.1	29.3	0.6	0.0	0.0	0.0	0.0	0.0	31.5	0.0	1.1	1.0	0.0	0.0	0.0	14.4	0.6	0.0	0.1	4.3	0.0	0.0
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160753315	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 269.9"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1391.0"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HL-60: 3.6;RH-30: 4.0;U-698: 2.0;U-937: 1.6"									"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	41000000000			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	269.9	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.2	0.9	0.0	0.0	0.4	4.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.0	0.0	2.0	0.0	1.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	2.2	0.0	0.0	0.0	0.6	28.1	2.7	0.0	1.8	0.0	0.0	16.6	0.0	0.1	0.0	0.0	23.3	0.0	0.0	0.0	0.0	1.1	1391.0	0.1	0.0	0.0	26.4	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	203.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.9	0.0	0.0
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 3314.2"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 29973.4"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 139.3;monocytes: 203.0"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 326.1"					"Region enriched"	"Detected in many"	6	"cerebellum: 334.2"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	210000000000	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	0.9	0.4	0.7	4.9	1.4	3.0	2.4	0.2	0.7	2.6	7.5	0.5	3.1	6.3	0.8	8.6	0.4	0.7	14.2	1.0	0.4	0.5	74.1	3314.2	13.6	5.3	1.0	0.2	0.6	7.4	0.0	0.4	0.8	0.8	0.6	4.1	0.6	0.9	3.6	0.2	0.3	36.2	1.4	1.3	8.9	7.0	0.8	0.8	0.5	0.8	0.2	0.9	0.5	0.6	0.3	33.5	139.3	203.0	0.2	0.3	100.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	12.9	41.0	0.1	1.1	0.0	0.1	0.1	0.0	0.8	0.0	5.0	0.0	0.2	0.1	326.1	0.0	1.1	0.1	0.3	0.4	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.5	0.1	1.1	0.1	22.1	0.2	0.0	0.1	0.4	0.1	0.1	0.0	19.4	0.2	0.1	0.1	5.1	0.1	0.6	0.2	0.1	0.5	0.3	2.8	0.0	0.4	110.2	29.1	0.2	165.9	0.3	0.3	0.1	0.2	33.5	0.1	0.2	0.1	139.3	0.2	203.0	0.7	0.2	100.0	0.7	1.4	0.2	0.7	0.4	0.5	1.0	0.2	0.8	0.8	32.8	233.5	435.3	1.1	2.1	0.0	2.8	4603.8	45.5	60.3	143.1	0.0	1.4	58.0	1848.5	0.1	6.6	53.3	817.7	189.3	1.7	1.6	5.0	1.1	29973.4	171.4	0.0	11.6	922.6	1276.8	0.0	0.0	188.6	1.7	107.4	659.1	0.3	1376.2	37.4	0.0	447.0	0.2	0.0	5.1	0.0	0.1	1.5	5.4	46.5	24.7	7.1
SERPINA3	"AACT, ACT"	ENSG00000196136	"Serpin family A member 3"	P01011	14	94612377-94624055	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 1244.8"	"Cell type enhanced"	"Detected in some"	17	"Ductal cells: 13.4;Exocrine glandular cells: 28.2;Pancreatic endocrine cells: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 98.6"									"HPA000893, HPA002560, CAB016647"	Enhanced				"Secreted to blood"	NA	NA	697000000000	95000000000			"CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717"	"prognostic favorable (8.92e-4)"	"unprognostic (3.33e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.74e-12)"	"unprognostic (6.47e-2)"	"unprognostic (1.33e-2)"		"unprognostic (2.02e-2)"	11.1	2.1	5.4	5.7	17.6	1.2	26.0	1.9	16.1	43.8	2.3	10.0	1.4	2.3	2.2	2.4	3.3	4.3	18.1	10.7	13.4	6.5	61.9	1244.8	4.9	53.0	16.3	0.8	8.3	182.4	1.0	14.0	2.7	34.2	18.3	2.6	10.2	62.1	7.9	6.8	1.5	2.3	10.2	47.2	8.2	9.7	9.5	7.4	0.0	3.5	0.5	1.7	7.6	11.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.1	1.0	0.0	0.7	0.2	0.0	0.9	0.0	0.6	0.0	0.2	0.0	98.6	13.4	0.4	0.1	12.2	14.7	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.1	0.1	0.3	0.0	0.1	0.5	0.0	0.8	0.0	0.0	0.0	0.4	0.5	14.4	0.1	0.5	0.0	0.1	0.0	1.8	0.0	4.2	0.2	0.3	0.4	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.4	17.6	1.9	9.6	13.4	6.5	16.3	0.8	34.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	13.4	3.9	0.0	0.0	0.0	28.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.8	0.0	0.2	28.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	22.2	20.2	9.3	18.9	20.6	12.0	58.3	31.8	24.2	22.4	37.2	49.3	20.5	22.8	60.4	11.8	49.0	34.3	31.9	10.5	27.5	109.0	10.8	86.4	17.3	22.9	16.3	70.8	17.5	13.5	10.4	19.3	17.4	6.4	7.4	12.6	36.0	21.9	17.5	20.6	23.2	15.0	28.4	29.3	41.5	12.3	13.8	27.3	20.1	56.3	21.3	8.8	30.7	80.8	7.2	16.1	78.4	14.8	9.5	26.7	21.7	23.3	47.6	6.2	48.1	35.6	31.2	19.2	16.1	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1	41.7	27.2	29.6	33.6	53.5	48.1	81.5	45.9	28.1	26.1	19.2	139.4	104.0	0.0	43.1	2.6	17.8	72.1	560.6	36.6	18.5	33.8	15.8	22.0	94.1	70.3	12.7	53.9	6.7	33.3	3.9	10.6	89.7	16.9	72.1	50.0	17.3	38.9	52.6	8.1	9.1	42.4	25.8	34.8	22.3	19.3	31.2	420.4	21.8	70.2	22.9